GlaxoSmithKline "deliberately" discontinued a widely-used asthma medication in order to reap profits and families suffered, ...

Ms. Fogarty has served at Tonix since 2016, most recently as Executive Vice President, Product Development Tonix is Preparing ...

In a report released on February 5, David Evans from Kepler Capital maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with ...

UBS analyst Jo Walton maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £15.80. The company’s ...

Spandana Sphoorty Financial Ltd, Reliance Power Ltd, Fusion Finance Ltd and Aarti Pharmalabs Ltd are among the other gainers in the BSE's 'A' group today, 06 February 2025.

Sir Jonathan Van-Tam will work across the Health & Life Sciences client portfolio as it growsLONDON, Feb. 03, 2025 (GLOBE ...

Ms. Fogarty has served at Tonix since 2016, most recently as Executive Vice President, Product Development Tonix is Preparing for Potential Launch of TNX-102 SL for the management of fibromyalgia with ...

and Director of Communications and Public Relations at SmithKline Beecham Corporation. After a successful career, he founded Price & Associates, consulting for notable entities like the Greater ...

CFRA analyst Wan Nurhayati revised the price target for GlaxoSmithKline (NYSE:GSK) shares, reducing it to $40.00 from the ...

Funding from Reliant Pharmaceuticals, Inc., a subsidiary of SmithKline Beecham Corporation, helped support the preparation of this paper for publication. Dr Tighe is an employee of Scientiae ...

in 0.45% sodium chloride injection SP 0.85 mL/min Ticarcillin-clavulanic acid SmithKline Beecham NR3533 3.1 g (103.3 mg/mL) in 0.45% sodium chloride injection SP 0.85 mL/min Tobramycin NOVA Plus ...

Also, they relocated the SmithKline & French plant from Mumbai to Bangalore. In the year 1983, they commissioned the Nashik factory. SmithKline & Beecham became a public limited company under the ...